Summary
For Year 2026-27, Ishita Drugs & Industries reports the following shareholding: Total Promoters at 50.04%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 49.96%. This breakdown provides a quick snapshot of ownership distribution for Ishita Drugs & Industries in 2026-27.
Ishita Drugs & Industries FAQs
As of 04-2026, the promoter shareholding in Ishita Drugs & Industries stands at 50.04% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Ishita Drugs & Industries is 0% and 0% respectively.
The retail shareholding of the Ishita Drugs & Industries is 49.96%.
Changes in shareholding patterns of Ishita Drugs & Industries can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Ishita Drugs & Industries are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Ishita Drugs & Industries Associated Pages
- Ishita Drugs & Industries Share Price
- Ishita Drugs & Industries Share Price chart
- Ishita Drugs & Industries Fundamental Analysis
- Ishita Drugs & Industries Technical Analysis
- Ishita Drugs & Industries Peer Comparison
- Ishita Drugs & Industries Share Price History
- Ishita Drugs & Industries Board of Directors
